Amy E. Colson

957 total citations
17 papers, 348 citations indexed

About

Amy E. Colson is a scholar working on Infectious Diseases, Emergency Medicine and Virology. According to data from OpenAlex, Amy E. Colson has authored 17 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 5 papers in Emergency Medicine and 4 papers in Virology. Recurrent topics in Amy E. Colson's work include HIV/AIDS Research and Interventions (10 papers), HIV/AIDS drug development and treatment (10 papers) and HIV-related health complications and treatments (5 papers). Amy E. Colson is often cited by papers focused on HIV/AIDS Research and Interventions (10 papers), HIV/AIDS drug development and treatment (10 papers) and HIV-related health complications and treatments (5 papers). Amy E. Colson collaborates with scholars based in United States, United Kingdom and France. Amy E. Colson's co-authors include Paul E. Sax, Peter W. Choo, Marla J. Keller, Richard Platt, Karen McLaughlin, Calvin Cohen, Gene D. Morse, Gerald Pierone, Timothy Wilkin and Michael S. Saag and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and AIDS.

In The Last Decade

Amy E. Colson

17 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy E. Colson United States 8 296 180 64 61 57 17 348
Nicola Mackie United Kingdom 13 369 1.2× 275 1.5× 99 1.5× 98 1.6× 37 0.6× 31 448
N Abrescia Italy 7 212 0.7× 100 0.6× 75 1.2× 75 1.2× 26 0.5× 20 292
Sara Melzi Italy 9 270 0.9× 154 0.9× 153 2.4× 59 1.0× 21 0.4× 10 377
Jamie C. Jordan United States 9 243 0.8× 119 0.7× 64 1.0× 68 1.1× 17 0.3× 9 467
Sofía Ibarra Spain 11 155 0.5× 59 0.3× 113 1.8× 59 1.0× 57 1.0× 20 309
Cynthia X. Shi United States 11 193 0.7× 75 0.4× 25 0.4× 167 2.7× 22 0.4× 20 293
Elías Rodríguez Rodríguez Spain 4 243 0.8× 69 0.4× 64 1.0× 108 1.8× 9 0.2× 11 337
Paola Nasta Italy 12 216 0.7× 106 0.6× 97 1.5× 167 2.7× 27 0.5× 42 404
Jacob Langness United States 7 305 1.0× 127 0.7× 45 0.7× 163 2.7× 9 0.2× 10 381
Ron Rosenes Canada 11 187 0.6× 104 0.6× 123 1.9× 172 2.8× 8 0.1× 31 392

Countries citing papers authored by Amy E. Colson

Since Specialization
Citations

This map shows the geographic impact of Amy E. Colson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Colson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Colson more than expected).

Fields of papers citing papers by Amy E. Colson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy E. Colson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Colson. The network helps show where Amy E. Colson may publish in the future.

Co-authorship network of co-authors of Amy E. Colson

This figure shows the co-authorship network connecting the top 25 collaborators of Amy E. Colson. A scholar is included among the top collaborators of Amy E. Colson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy E. Colson. Amy E. Colson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Colson, Amy E., Peter Ruane, Moti Ramgopal, et al.. (2025). 577. Week 48 Results of a Phase 2 Study Evaluating Once-weekly Oral Islatravir Plus Lenacapavir. Open Forum Infectious Diseases. 12(Supplement_1). 2 indexed citations
3.
4.
Colson, Amy E., et al.. (2024). Health care resource utilization and costs for treatment-experienced people with HIV switching or restarting antiretroviral regimens since 2018. Journal of Managed Care & Specialty Pharmacy. 30(8). 817–824. 2 indexed citations
5.
Colson, Amy E., et al.. (2024). Persistence in treatment-experienced people with HIV switching anti-retroviral therapy regimens since 2018. Future Virology. 19(10-11). 371–380. 3 indexed citations
6.
Mauhin, Wladimir, Amy E. Colson, Jonathan London, et al.. (2021). Syndrome multicarentiel catastrophique post bypass gastrique. La Revue de Médecine Interne. 42(10). 729–733. 1 indexed citations
7.
Skiest, Daniel J., Calvin Cohen, Karam Mounzer, et al.. (2011). Similar Efficacy of Raltegravir When Used With or Without a Protease Inhibitor in Treatment-Experienced Patients. HIV Clinical Trials. 12(3). 131–140. 5 indexed citations
8.
Cohen, C, Amy E. Colson, Gerald Pierone, et al.. (2008). O214 The FOTO study: 24-week results support the safety of a 2-day break on efavirenz-based antiretroviral therapy. Journal of the International AIDS Society. 11(Suppl 1). O19–O19. 7 indexed citations
9.
Haubrich, Richard, Philippe Chiliade, Amy E. Colson, et al.. (2007). Week 24 efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients. AIDS. 21(6). F11–F18. 96 indexed citations
10.
11.
Colson, Amy E., et al.. (2002). Male Sexual Dysfunction Associated With Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 30(1). 27–32. 9 indexed citations
12.
Colson, Amy E., et al.. (2002). Male Sexual Dysfunction Associated With Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 30(1). 27–32. 60 indexed citations
13.
Colson, Amy E., et al.. (2001). Paronychia in Association with Indinavir Treatment. Clinical Infectious Diseases. 32(1). 140–143. 9 indexed citations
14.
Pitt, Jason J., Kenneth McIntosh, Amy E. Colson, et al.. (2000). HIV-1 genotypic zidovudine drug resistance and the risk of maternal–infant transmission in the Women and Infants Transmission Study*. AIDS. 14(3). 263–271. 69 indexed citations
15.
Colson, Amy E. & Paul E. Sax. (2000). Sexual dysfunction and HIV infection.. PubMed. 12(5). 39–41, 43, 45. 8 indexed citations
16.
Colson, Amy E. & Johanna P. Daily. (1999). Orbital Apex Syndrome and Cavernous Sinus Thrombosis Due to Infection with Staphylococcus aureus and Pseudomonas aeruginosa. Clinical Infectious Diseases. 29(3). 701–702. 15 indexed citations
17.
Welles, Seth L., Jane Pitt, Amy E. Colson, et al.. (1997). Molecular ZDV-resis tance and the risk of perinatal HIV-1 transmission in the women & infants transmission study. 25(2). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicola Mackie Breakdown of academic impact, for papers by N Abrescia Breakdown of academic impact, for papers by Sara Melzi Breakdown of academic impact, for papers by Jamie C. Jordan Breakdown of academic impact, for papers by Sofía Ibarra Breakdown of academic impact, for papers by Cynthia X. Shi Breakdown of academic impact, for papers by Elías Rodríguez Rodríguez Breakdown of academic impact, for papers by Paola Nasta Breakdown of academic impact, for papers by Jacob Langness Breakdown of academic impact, for papers by Ron Rosenes
Rankless by CCL
2026